Literature DB >> 9430811

A cross-sectional survey of pain and pharmacological analgesia in Canadian neonatal intensive care units.

C C Johnston1, J M Collinge, S J Henderson, K J Anand.   

Abstract

OBJECTIVE: To determine current practices for the use of analgesia term and preterm neonates cared for in Neonatal Intensive Care Units (NICUs).
DESIGN: One-week survey of medical charts of current patients.
SETTING: NICUs in Canada. PARTICIPANTS: A total of 14 of 38 invited NICUs participated. These units were not different on number of beds, admissions per year, or university affiliation from the nonparticipating units. MAIN OUTCOME MEASURES: Daily logs were kept of the frequency and type of procedures and analgesia administration for all ill neonates in each NICU during the study period.
RESULTS: The sample consisted of 239 patients. A total of 2,134 invasive procedures were performed. Medication was given specifically 18 times for 17 invasive procedures (0.8%). For another 129 invasive procedures, the patient was receiving analgesia for reasons other than the procedure. Sixteen patients had surgery during the survey period, and another 14 had surgery prior to but within 4 days of the survey. Fifty-one patients received anaesthesia or analgesia specifically related to surgery (39 times), procedures (35 times), or other reasons (34 times), a total of 108 courses. Opioids were the most frequently used medications and were given for all reasons, by continuous infusion, intermittent bolus, or sometimes both methods for the same patient.
CONCLUSIONS: Postoperative pain in neonates in Canadian NICUs appears to be consistently treated, primarily with opioid analgesics, but analgesia, opioid or nonopioid is rarely given for nonsurgical invasive procedures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430811     DOI: 10.1097/00002508-199712000-00008

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  37 in total

1.  Can we use methadone for analgesia in neonates?

Authors:  S K Chana; K J Anand
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

Review 2.  The effects of early pain experience in neonates on pain responses in infancy and childhood.

Authors:  Anna Taddio; Joel Katz
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 3.  Pharmacological therapy for analgesia and sedation in the newborn.

Authors:  K J S Anand; R W Hall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

4.  Randomised controlled trial evaluating effects of morphine on plasma adrenaline/noradrenaline concentrations in newborns.

Authors:  S H P Simons; M van Dijk; R A van Lingen; D Roofthooft; F Boomsma; J N van den Anker; D Tibboel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

Review 5.  Blood sampling in infants (reducing pain and morbidity).

Authors:  Olga Kapellou
Journal:  BMJ Clin Evid       Date:  2009-01-07

6.  Are there long-term consequences of pain in newborn or very young infants?

Authors:  Gayle Giboney Page
Journal:  J Perinat Educ       Date:  2004

Review 7.  Blood sampling in infants (reducing pain and morbidity).

Authors:  Olga Kapellou
Journal:  BMJ Clin Evid       Date:  2011-04-05

8.  Examining nurse empathy for infant procedural pain: Testing a new video measure.

Authors:  Margot Latimer; Philip Jackson; Celeste Johnston; Jocelyn Vine
Journal:  Pain Res Manag       Date:  2011 Jul-Aug       Impact factor: 3.037

9.  Morphine in ventilated neonates: its effects on arterial blood pressure.

Authors:  S H P Simons; D W E Roofthooft; M van Dijk; R A van Lingen; H J Duivenvoorden; J N van den Anker; D Tibboel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-08-30       Impact factor: 5.747

10.  Pain and stress management in the Neonatal Intensive Care Unit--a national survey in Austria.

Authors:  Klaudia Rohrmeister; Veronika Kretzer; Angelika Berger; Nadja Haiden; Christina Kohlhauser; Arnold Pollak
Journal:  Wien Klin Wochenschr       Date:  2003-10-31       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.